In summary, LH capsules confer therapeutic effects on Covid-19 by improving the recovery rate of symptoms, shortening the time to symptom recovery, and improving the recovery of chest radiologic ab- normalities. In light of the efficacy and safety profiles, LH capsules could be considered for the treatment of Covid-19. Future double-blind, pro- spective, randomized controlled trials are needed to fully evaluate the efficacy of LH capsules in a larger patient population.
admin
Association of Participation in the Maryland Primary Care Program With COVID-19 Outcomes Among Medicare Beneficiaries
Sorry, this entry is only available in 中文.類型: 連結 作者: Emily Gruber et al. 出處: Jamanetwork 連結:...
Enhanced transmissibility of XBB.1.5 is contributed by both strong ACE2 binding and antibody evasion
Sorry, this entry is only available in 中文.類型: 連結 作者: Can Yue et al. 出處: Biorxiv 連結:...
Capillary Leak Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccines: A Comparative Review
Sorry, this entry is only available in 中文.類型: 連結 作者: Zeinab Mohseni Afshar et al. 出處: Preprints 連結:...
RTHK 精靈一點:2023.01.03 尋麻疹(二)
Sorry, this entry is only available in 中文.節目內容:Click here
COVID-19 Rehabilitation
Sorry, this entry is only available in 中文.類型: 連結 作者: Aapmr 出處: Aapmr 連結:...
Broad Anti-Viral Capacities of Lian-Hua-Qing-Wen Capsule and Jin-Hua-Qing-Gan Granule and Rational use Against COVID-19 Based on Literature Mining
Here, we desired to analyze the broad-spectrum anti-viral capacities of LHQWC and JHQGG, and to compare their pharmacological functions for rational clinical applications. Based on literature mining, we found that both LHQWC and JHQGG were endowed with multiple antiviral activities by both targeting viral life cycle and regulating host immune responses and inflammation. In addition, from literature analyzed, JHQGG is more potent in modulating viral life cycle, whereas LHQWC exhibits better efficacies in regulating host anti-viral responses. When translating into clinical applications, oral administration of LHQWC could be more beneficial for patients with insufficient immune functions or for patients with alleviated symptoms after treatment with JHQGG.
What ‘s New in the Guidelines
Sorry, this entry is only available in 中文.類型: 連結 作者: NIH 出處: NIH 連結:...
What ‘s New in the Guidelines
Sorry, this entry is only available in 中文.類型: 連結 作者: NIH 出處: NIH 連結:...
What ‘s New in the Guidelines
Sorry, this entry is only available in 中文.類型: 連結 作者: NIH 出處: NIH 連結:...